These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20614012)

  • 1. HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.
    Li G; Elder RT; Dubrovsky L; Liang D; Pushkarsky T; Chiu K; Fan T; Sire J; Bukrinsky M; Zhao RY
    PLoS One; 2010 Jun; 5(6):e11371. PubMed ID: 20614012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of HIV-1 Vpr protein to the human homolog of the yeast DNA repair protein RAD23 (hHR23A) requires its xeroderma pigmentosum complementation group C binding (XPCB) domain as well as the ubiquitin-associated 2 (UBA2) domain.
    Jung J; Byeon IJ; DeLucia M; Koharudin LM; Ahn J; Gronenborn AM
    J Biol Chem; 2014 Jan; 289(5):2577-88. PubMed ID: 24318982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of HIV-1 Vpr in complex with the human nucleotide excision repair protein hHR23A.
    Byeon IL; Calero G; Wu Y; Byeon CH; Jung J; DeLucia M; Zhou X; Weiss S; Ahn J; Hao C; Skowronski J; Gronenborn AM
    Nat Commun; 2021 Nov; 12(1):6864. PubMed ID: 34824204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Vpr Reprograms CLR4
    Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
    mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.
    Mansky LM; Preveral S; Le Rouzic E; Bernard LC; Selig L; Depienne C; Benarous R; Benichou S
    Virology; 2001 Mar; 282(1):176-85. PubMed ID: 11259200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr.
    Gragerov A; Kino T; Ilyina-Gragerova G; Chrousos GP; Pavlakis GN
    Virology; 1998 Jun; 245(2):323-30. PubMed ID: 9636371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
    Gibbons JM; Marno KM; Pike R; Lee WJ; Jones CE; Ogunkolade BW; Pardieu C; Bryan A; Fu RM; Warnes G; Rowley PA; Sloan RD; McKnight Á
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
    Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
    Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
    Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression.
    Wang Q; Su L
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.
    Le Rouzic E; Morel M; Ayinde D; Belaïdouni N; Letienne J; Transy C; Margottin-Goguet F
    J Biol Chem; 2008 Aug; 283(31):21686-92. PubMed ID: 18524771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair.
    Withers-Ward ES; Jowett JB; Stewart SA; Xie YM; Garfinkel A; Shibagaki Y; Chow SA; Shah N; Hanaoka F; Sawitz DG; Armstrong RW; Souza LM; Chen IS
    J Virol; 1997 Dec; 71(12):9732-42. PubMed ID: 9371639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
    Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
    J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells.
    Yan J; Shun MC; Zhang Y; Hao C; Skowronski J
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9568-9577. PubMed ID: 31019079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway.
    Zhou D; Wang Y; Tokunaga K; Huang F; Sun B; Yang R
    Virus Res; 2015 Jan; 195():25-34. PubMed ID: 25200749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.
    Zhang F; Bieniasz PD
    Elife; 2020 Jun; 9():. PubMed ID: 32538781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vpr-host interactions during HIV-1 viral life cycle.
    Zhao RY; Li G; Bukrinsky MI
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):216-29. PubMed ID: 21318276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.
    Zhou T; Dang Y; Baker JJ; Zhou J; Zheng YH
    Retrovirology; 2012 Nov; 9():93. PubMed ID: 23134572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.
    DeHart JL; Zimmerman ES; Ardon O; Monteiro-Filho CM; Argañaraz ER; Planelles V
    Virol J; 2007 Jun; 4():57. PubMed ID: 17559673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Arginine
    Murakami H; Suzuki T; Tsuchiya K; Gatanaga H; Taura M; Kudo E; Okada S; Takei M; Kuroda K; Yamamoto T; Hagiwara K; Dohmae N; Aida Y
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32210193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.